Triple-negative Breast Cancer
📧 Sign up to get email alerts when something new happens for Triple-negative Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Omission of Surgery for Triple-negative Breast Cancer in Complete Response After Neoadjuvant Chemo-immunotherapy [NA]
A clinical trial update indicates that surgery may be omitted for patients with triple-negative breast cancer who achieve complete response …
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Pilot Study of Veliparib (ABT-888) and Lapatinib (Tykerb) in Patients With Metastatic, Triple Negative Breast Cancer [NA]
This is a completed pilot trial evaluating veliparib in combination with lapatinib in patients with metastatic triple-negative breast cancer…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors. [Phase 1]
A Phase 1 study evaluating DKY709 alone or in combination with PDR001 in patients with advanced solid tumors. The enrolled diseases include …
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer [Phase 1]
A Phase 1 trial of A2-ESO-1 TCR-Engineered T Cells for NY-ESO-1 overexpression positive triple negative breast cancer has been suspended. Th…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Intratumoral N17350 in Advanced Solid Tumors [Phase 1, Phase 2]
Update on the investigational intratumoral therapy N17350 being studied in advanced solid tumors in Phase 1 and Phase 2 trials, sponsored by…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy With Atezolizumab - CTX Therapy [Phase 2]
A Phase 2 trial comparing a mono atezolizumab window followed by atezolizumab–cyclophosphamide therapy versus atezolizumab–cyclophosphamide …
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers [Phase 1, Phase 2]
A Phase 1/2 study of OC-001 in locally advanced or metastatic cancers has been terminated according to its clinical trials registry listing.
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors [Phase 1]
Phase 1 study of Felmetatug Vedotin (SGN-B7H4V) in advanced solid tumors was terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: A Phase 1 Study of [225Ac]-FPI-1434 Injection [Phase 1]
A Phase 1 study of [225Ac]-FPI-1434 injection sponsored by Fusion Pharmaceuticals has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: A Study to Evaluate the Efficacy and Toxicities of PLX038, in Patients With Locally Advanced or Metastatic Triple-negative Breast Cancer [Phase 2]
A Phase 2 study evaluating PLX038 for locally advanced or metastatic triple-negative breast cancer has been terminated, according to the cli…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Ribociclib and Bicalutamide in AR+ TNBC [Phase 1, Phase 2]
This clinical trial update reports a Phase 1/2 study of ribociclib in combination with bicalutamide for AR-positive triple-negative breast c…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Imaging Performance Assessment of 89Zi-girentuximab (89Zr-TLX250) PET in Metastatic Triple Negative Breast Cancer [Phase 2]
Phase 2 imaging study assessing the performance of 89Zr-TLX250 PET in metastatic triple-negative breast cancer; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Olinvacimab With Pembrolizumab in Patients With mTNBC [Phase 2]
A Phase 2 study evaluating Olinvacimab in combination with pembrolizumab for metastatic triple-negative breast cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: A Study of Atezolizumab Plus Nab-Paclitaxel in the Treatment of Unresectable Locally Advanced or Metastatic PD-L1-Positive Triple-Negative Breast Cancer [Phase 3]
This Phase 3 trial assesses atezolizumab plus nab-paclitaxel for unresectable locally advanced or metastatic PD-L1-positive triple-negative …
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors [Phase 2]
Phase 2 clinical trial of TJ004309 in combination with atezolizumab (TECENTRIQ) for ovarian cancer and selected solid tumors has completed e…
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating SGN-LIV1A in combination with pembrolizumab for locally advanced or metastatic triple-negative breast…
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: Adjuvant Treatment for High-risk Triple Negative Breast Cancer Patients With the Anti-PD-l1 Antibody Avelumab [Phase 3]
A Phase 3 trial evaluating adjuvant avelumab for high-risk triple-negative breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: SKB264 Injection vs Investigator Selected Regimens to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer [Phase 3]
A Phase 3 clinical trial comparing SKB264 injection against investigator-selected regimens for locally advanced, recurrent, or metastatic tr…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy [Phase 1]
A Phase 1 study evaluating the safety and preliminary efficacy of combining rucaparib with radiation in triple-negative breast cancer patien…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer [Phase 2]
A Phase 2 trial evaluating Vidutolimod in combination with cemiplimab for adults with advanced or metastatic cancers was terminated, with re…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Preventive stRategy for IMMU132-relatED AEs in TNBC or Luminal Breast Cancer- PRIMED [Phase 2]
A Phase 2 trial (PRIMED) evaluating a preventive strategy for IMMU132-related adverse events in triple-negative and HR+/HER2-negative breast…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Multicentre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Three Standard of Care Regimens for The Treatment of Triple-Negative Breast Cancer in the Neoadjuvant/Adjuvant Setting (REaCT-TNBC) [Phase 4]
A Phase 4 multicenter study (REaCT-TNBC) evaluating an integrated consent model while comparing three standard-of-care regimens for triple-n…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast Cancer [Phase 2]
Phase 2 trial update evaluating pembrolizumab with IRX-2 and chemotherapy in triple-negative breast cancer; the study is active but not recr…
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC) [Phase 1]
A Phase 1 study evaluating olaparib in combination with radiation therapy for triple-negative breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: AMTEC IIT: Phase 2 Multiarm Study in TNBC [Phase 2]
Phase 2 multiarm AMTEC IIT trial in metastatic/triple-negative breast cancer has been terminated; results have been posted on 2025-11-21.